Selected research
Industry Growth & Trends
Global Mouth-dissolving Tablets Industry Growth and Trends Forecast to 2032
Market perspective
The global Mouth-dissolving Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Mouth-dissolving Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Mouth-dissolving Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mouth-dissolving Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Mouth-dissolving Tablets include Teva, Johnson and Johnson, Merck, Mylan, Eli Lilly and Company, Pfizer, GSK, AstraZeneca and Otsuka, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Mouth-dissolving Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Mouth-dissolving Tablets market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mouth-dissolving Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mouth-dissolving Tablets.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Mouth-dissolving Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Mouth-dissolving Tablets Market by Company
Teva
Johnson and Johnson
Merck
Mylan
Eli Lilly and Company
Pfizer
GSK
AstraZeneca
Otsuka
Conquer
Bristol-Myers Squibb
Mouth-dissolving Tablets Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Mouth-dissolving Tablets Segment by Application
CVS Diseases
Gastrointestinal Diseases
CNS Diseases
Other
Mouth-dissolving Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mouth-dissolving Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mouth-dissolving Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mouth-dissolving Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mouth-dissolving Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Mouth-dissolving Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-Psychotics Drug
- Anti-Epileptics Drug
- Other
Applications
- CVS Diseases
- Gastrointestinal Diseases
- CNS Diseases
- Other
Companies covered
- Teva
- Johnson and Johnson
- Merck
- Mylan
- Eli Lilly and Company
- Pfizer
- GSK
- AstraZeneca
- Otsuka
- Conquer
- Bristol-Myers Squibb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Mouth-dissolving Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Mouth-dissolving Tablets Sales Estimates and Forecasts (2021-2032)
- 1.3 Mouth-dissolving Tablets Market by Type
- 1.3.1 Anti-Psychotics Drug
- 1.3.2 Anti-Epileptics Drug
- 1.3.3 Other
- 1.4 Global Mouth-dissolving Tablets Market Size by Type
- 1.4.1 Global Mouth-dissolving Tablets Market Size Overview by Type (2021-2032)
- 1.4.2 Global Mouth-dissolving Tablets Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Mouth-dissolving Tablets Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Mouth-dissolving Tablets Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Mouth-dissolving Tablets Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Mouth-dissolving Tablets Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Mouth-dissolving Tablets Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Mouth-dissolving Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Mouth-dissolving Tablets Industry Trends
- 2.2 Mouth-dissolving Tablets Industry Drivers
- 2.3 Mouth-dissolving Tablets Industry Opportunities and Challenges
- 2.4 Mouth-dissolving Tablets Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Mouth-dissolving Tablets Revenue (2021-2026)
- 3.2 Global Top Players by Mouth-dissolving Tablets Sales (2021-2026)
- 3.3 Global Top Players by Mouth-dissolving Tablets Price (2021-2026)
- 3.4 Global Mouth-dissolving Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Mouth-dissolving Tablets Major Company Production Sites & Headquarters
- 3.6 Global Mouth-dissolving Tablets Company, Product Type & Application
- 3.7 Global Mouth-dissolving Tablets Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Mouth-dissolving Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Mouth-dissolving Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Mouth-dissolving Tablets Tier 1, Tier 2, and Tier 3
4 Mouth-dissolving Tablets Regional Status and Outlook
- 4.1 Global Mouth-dissolving Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Mouth-dissolving Tablets Historic Market Size by Region
- 4.2.1 Global Mouth-dissolving Tablets Sales in Volume by Region (2021-2026)
- 4.2.2 Global Mouth-dissolving Tablets Sales in Value by Region (2021-2026)
- 4.2.3 Global Mouth-dissolving Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Mouth-dissolving Tablets Forecasted Market Size by Region
- 4.3.1 Global Mouth-dissolving Tablets Sales in Volume by Region (2027-2032)
- 4.3.2 Global Mouth-dissolving Tablets Sales in Value by Region (2027-2032)
- 4.3.3 Global Mouth-dissolving Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mouth-dissolving Tablets by Application
- 5.1 Mouth-dissolving Tablets Market by Application
- 5.1.1 CVS Diseases
- 5.1.2 Gastrointestinal Diseases
- 5.1.3 CNS Diseases
- 5.1.4 Other
- 5.2 Global Mouth-dissolving Tablets Market Size by Application
- 5.2.1 Global Mouth-dissolving Tablets Market Size Overview by Application (2021-2032)
- 5.2.2 Global Mouth-dissolving Tablets Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Mouth-dissolving Tablets Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Mouth-dissolving Tablets Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Mouth-dissolving Tablets Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Mouth-dissolving Tablets Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Mouth-dissolving Tablets Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Mouth-dissolving Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Mouth-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Mouth-dissolving Tablets Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Johnson and Johnson
- 6.2.1 Johnson and Johnson Company Information
- 6.2.2 Johnson and Johnson Business Overview
- 6.2.3 Johnson and Johnson Mouth-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Johnson and Johnson Mouth-dissolving Tablets Product Portfolio
- 6.2.5 Johnson and Johnson Recent Developments
- 6.3 Merck
- 6.3.1 Merck Company Information
- 6.3.2 Merck Business Overview
- 6.3.3 Merck Mouth-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merck Mouth-dissolving Tablets Product Portfolio
- 6.3.5 Merck Recent Developments
- 6.4 Mylan
- 6.4.1 Mylan Company Information
- 6.4.2 Mylan Business Overview
- 6.4.3 Mylan Mouth-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Mylan Mouth-dissolving Tablets Product Portfolio
- 6.4.5 Mylan Recent Developments
- 6.5 Eli Lilly and Company
- 6.5.1 Eli Lilly and Company Company Information
- 6.5.2 Eli Lilly and Company Business Overview
- 6.5.3 Eli Lilly and Company Mouth-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Eli Lilly and Company Mouth-dissolving Tablets Product Portfolio
- 6.5.5 Eli Lilly and Company Recent Developments
- 6.6 Pfizer
- 6.6.1 Pfizer Company Information
- 6.6.2 Pfizer Business Overview
- 6.6.3 Pfizer Mouth-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Pfizer Mouth-dissolving Tablets Product Portfolio
- 6.6.5 Pfizer Recent Developments
- 6.7 GSK
- 6.7.1 GSK Company Information
- 6.7.2 GSK Business Overview
- 6.7.3 GSK Mouth-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 GSK Mouth-dissolving Tablets Product Portfolio
- 6.7.5 GSK Recent Developments
- 6.8 AstraZeneca
- 6.8.1 AstraZeneca Company Information
- 6.8.2 AstraZeneca Business Overview
- 6.8.3 AstraZeneca Mouth-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 AstraZeneca Mouth-dissolving Tablets Product Portfolio
- 6.8.5 AstraZeneca Recent Developments
- 6.9 Otsuka
- 6.9.1 Otsuka Company Information
- 6.9.2 Otsuka Business Overview
- 6.9.3 Otsuka Mouth-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Otsuka Mouth-dissolving Tablets Product Portfolio
- 6.9.5 Otsuka Recent Developments
- 6.10 Conquer
- 6.10.1 Conquer Company Information
- 6.10.2 Conquer Business Overview
- 6.10.3 Conquer Mouth-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Conquer Mouth-dissolving Tablets Product Portfolio
- 6.10.5 Conquer Recent Developments
- 6.11 Bristol-Myers Squibb
- 6.11.1 Bristol-Myers Squibb Company Information
- 6.11.2 Bristol-Myers Squibb Business Overview
- 6.11.3 Bristol-Myers Squibb Mouth-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Bristol-Myers Squibb Mouth-dissolving Tablets Product Portfolio
- 6.11.5 Bristol-Myers Squibb Recent Developments
7 North America by Country
- 7.1 North America Mouth-dissolving Tablets Sales by Country
- 7.1.1 North America Mouth-dissolving Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Mouth-dissolving Tablets Sales by Country (2021-2026)
- 7.1.3 North America Mouth-dissolving Tablets Sales Forecast by Country (2027-2032)
- 7.2 North America Mouth-dissolving Tablets Market Size by Country
- 7.2.1 North America Mouth-dissolving Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Mouth-dissolving Tablets Market Size by Country (2021-2026)
- 7.2.3 North America Mouth-dissolving Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Mouth-dissolving Tablets Sales by Country
- 8.1.1 Europe Mouth-dissolving Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Mouth-dissolving Tablets Sales by Country (2021-2026)
- 8.1.3 Europe Mouth-dissolving Tablets Sales Forecast by Country (2027-2032)
- 8.2 Europe Mouth-dissolving Tablets Market Size by Country
- 8.2.1 Europe Mouth-dissolving Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Mouth-dissolving Tablets Market Size by Country (2021-2026)
- 8.2.3 Europe Mouth-dissolving Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Mouth-dissolving Tablets Sales by Country
- 9.1.1 Asia-Pacific Mouth-dissolving Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Mouth-dissolving Tablets Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Mouth-dissolving Tablets Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Mouth-dissolving Tablets Market Size by Country
- 9.2.1 Asia-Pacific Mouth-dissolving Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Mouth-dissolving Tablets Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Mouth-dissolving Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Mouth-dissolving Tablets Sales by Country
- 10.1.1 South America Mouth-dissolving Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Mouth-dissolving Tablets Sales by Country (2021-2026)
- 10.1.3 South America Mouth-dissolving Tablets Sales Forecast by Country (2027-2032)
- 10.2 South America Mouth-dissolving Tablets Market Size by Country
- 10.2.1 South America Mouth-dissolving Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Mouth-dissolving Tablets Market Size by Country (2021-2026)
- 10.2.3 South America Mouth-dissolving Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Mouth-dissolving Tablets Sales by Country
- 11.1.1 Middle East and Africa Mouth-dissolving Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Mouth-dissolving Tablets Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Mouth-dissolving Tablets Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Mouth-dissolving Tablets Market Size by Country
- 11.2.1 Middle East and Africa Mouth-dissolving Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Mouth-dissolving Tablets Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Mouth-dissolving Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Mouth-dissolving Tablets Value Chain Analysis
- 12.1.1 Mouth-dissolving Tablets Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Mouth-dissolving Tablets Production Mode & Process
- 12.2 Mouth-dissolving Tablets Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Mouth-dissolving Tablets Distributors
- 12.2.3 Mouth-dissolving Tablets Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst